Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Affimed N.V. (AFMD)

Affimed N.V. (AFMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 611,345
  • Shares Outstanding, K 98,287
  • Annual Sales, $ 32,400 K
  • Annual Income, $ -47,250 K
  • 60-Month Beta 2.67
  • Price/Sales 18.99
  • Price/Cash Flow N/A
  • Price/Book 3.23
Trade AFMD with:

Options Overview Details

View History
  • Implied Volatility 80.40%
  • Historical Volatility 34.79%
  • IV Percentile 15%
  • IV Rank 14.45%
  • IV High 241.39% on 11/09/20
  • IV Low 53.22% on 08/18/21
  • Put/Call Vol Ratio 0.07
  • Today's Volume 297
  • Volume Avg (30-Day) 546
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 5,613
  • Open Int (30-Day) 6,499

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.08
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.99 +1.50%
on 09/28/21
7.34 -17.17%
on 08/30/21
-1.13 (-15.67%)
since 08/27/21
3-Month
5.43 +11.97%
on 08/20/21
8.64 -29.63%
on 06/30/21
-2.37 (-28.05%)
since 06/28/21
52-Week
3.09 +97.08%
on 11/02/20
11.74 -48.21%
on 04/26/21
+2.76 (+83.13%)
since 09/28/20

Most Recent Stories

More News
New Strong Sell Stocks for September 13th

AFMD, DZSI, GMBL, NTRB, and SURF have been added to the Zacks Rank #5 (Strong Sell) List on September 13, 2021.

AFMD : 6.06 (-2.57%)
DZSI : 12.64 (-0.47%)
SURF : 7.33 (-2.91%)
GMBL : 7.08 (-5.47%)
NTRB : 8.2500 (+26.92%)
Affimed N.V. (AFMD) Reports Q2 Loss, Lags Revenue Estimates

Affimed N.V. (AFMD) delivered earnings and revenue surprises of -171.43% and -13.79%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

AFMD : 6.06 (-2.57%)
Affimed N.V.: Q2 Earnings Snapshot

HEIDELBERG, Germany (AP) _ Affimed N.V. (AFMD) on Wednesday reported a loss of $22.6 million in its second quarter.

AFMD : 6.06 (-2.57%)
Affimed to Present at Upcoming Investor Conferences

Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that management will present and host one-on-one...

AFMD : 6.06 (-2.57%)
Affimed to Report Second Quarter 2021 Financial Results & Corporate Update on September 8, 2021

Affimed N.V. (Nasdaq: AFMD), a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it will release second quarter 2021 results...

AFMD : 6.06 (-2.57%)
Will Affimed N.V. (AFMD) Report Negative Q2 Earnings? What You Should Know

Affimed N.V. (AFMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AFMD : 6.06 (-2.57%)
Affimed N.V.: Q1 Earnings Snapshot

HEIDELBERG, Germany (AP) _ Affimed N.V. (AFMD) on Thursday reported first-quarter net income of $1.7 million, after reporting a loss in the same period a year earlier.

AFMD : 6.06 (-2.57%)
Affimed Reports First Quarter 2021 Financial Results and Highlights Operational Progress

Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today reported financial results for the quarter ended March...

AFMD : 6.06 (-2.57%)
Affimed to Report First Quarter 2021 Financial Results & Corporate Update July 1, 2021

Affimed N.V. (Nasdaq: AFMD), a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it will release first quarter 2021 results...

AFMD : 6.06 (-2.57%)
Home Sales Featured in U.S., Retail Sales in Canada

Monday U.S. Featured Earnings OncoSec Medical Incorporated (NASDAQ:ONCS) (Q3) EPS projected ...

ONCS : 2.20 (-5.58%)
AVAV : 86.14 (-0.13%)
AFMD : 6.06 (-2.57%)
INFO : 117.06 (-4.57%)
KBH : 40.17 (-3.09%)
FUL : 66.14 (+0.14%)
PDCO : 30.42 (-0.75%)
WGO : 72.85 (+6.41%)
SCS : 12.99 (+0.31%)
PAYX : 107.16 (-1.48%)
KMX : 143.37 (-1.29%)
JKS : 42.94 (-2.50%)
MDP.TO : 3.00 (-0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V.,...

See More

Key Turning Points

3rd Resistance Point 6.68
2nd Resistance Point 6.55
1st Resistance Point 6.38
Last Price 6.06
1st Support Level 6.08
2nd Support Level 5.95
3rd Support Level 5.78

See More

52-Week High 11.74
Fibonacci 61.8% 8.43
Fibonacci 50% 7.41
Fibonacci 38.2% 6.39
Last Price 6.06
52-Week Low 3.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar